Article Details

Aclaris Therapeutics (ACRS) Given “Buy” Rating at Cantor Fitzgerald

Retrieved on: 2018-07-25 19:14:12

Tags for this article:

Click the tags to see associated articles and topics

Aclaris Therapeutics (ACRS) Given “Buy” Rating at Cantor Fitzgerald. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in Aclaris Therapeutics during the 1st quarter valued at about $26,972,000. Citadel Advisors LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up